Picomole Inc.

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
Picomole is an innovative medical technology company. Our goal is to develop patented technologies to make breath analytics the standard of care for non-invasive clinical diagnostics and personalized medicine.
There are many applications for our technology to detect multiple diseases. We have chosen to begin with Lung Cancer as there is a very large market ($2.1B annually in the US) and a significant unmet medical need for lung cancer screening.

Our mission: To empower people with a simple breath test that provides early detection of cancer and other diseases.
Our vision: A non-invasive screening test to save lives.
Our focus: The commercialization of a non-invasive lung cancer screening test using Picomole’s patent-protected breath analytics technology.
Company Type:
Company Website:
Company HQ State:
New Brunswick
Company HQ Country:
Canada
Year Founded:
2005
Main Therapeutic Focus:
Lead Product in Development:
Lung Cancer Breath Test
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
Picomole Inc.